IL1R1 and complex regional pain syndrome: Inhibiting the IL-1 receptor 1 (IL-1R1) might be a potential therapeutic opportunity in chronic primary pain conditions such as fibromyalgia and complex regional pain syndrome, which are more common in female patients.